Drug Shortage Report for DIPRIVAN 1%
Report ID | 222698 |
Drug Identification Number | 02018950 |
Brand name | DIPRIVAN 1% |
Common or Proper name | propofol 1% 5x20mL Vial |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | PROPOFOL |
Strength(s) | 10MG |
Dosage form(s) | EMULSION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 vials |
ATC code | N01AX |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-05-15 |
Actual start date | |
Estimated end date | 2024-05-31 |
Actual end date | 2024-05-09 |
Shortage status | Avoided shortage |
Updated date | 2024-05-09 |
Company comments | VR44769CA1 DIPRIVAN 1% LIQ VIAL 5X20ML CA ASP |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-05-09 | French | Compare |
v10 | 2024-05-09 | English | Compare |
v9 | 2024-04-30 | French | Compare |
v8 | 2024-04-30 | English | Compare |
v7 | 2024-04-15 | French | Compare |
v6 | 2024-04-15 | English | Compare |
v5 | 2024-04-03 | French | Compare |
v4 | 2024-04-03 | English | Compare |
v3 | 2024-04-02 | English | Compare |
v2 | 2024-03-18 | French | Compare |
v1 | 2024-03-18 | English | Compare |
Showing 1 to 11 of 11